Physician organizations have an ethical obligation to advocate for general improvement of public health, even if it is sometimes at the expense of interests of medical professionals.
Mark McClellan, Commissioner of Food and Drugs, discusses pharmaceutical company research and the problems faced by funding for public health programs.
Physicians can ethically withhold information in situations where full disclosure of a diagnosis or treatment would cause great psychological harm to the patient.